Biogenomics Limited
Biogenomics Limited has proposed a new project in Sanand, Gujarat, aimed at manufacturing various types of insulin, including Insulin Aspart, Insulin Glargine, Insulin Lispro, and Insulin Degludec. The facility is set to produce these pharmaceutical products at a capacity of 0.05 TPM (tonnes per month).
Location: Ahmedabad Gujarat
Estimated Value (Rs. Cr): 204.61
Sector: Drugs/Pharma
Project Stage: Conceptual/Planning
Contact Details: You need to be a paid subscriber to get these details. Contacts are available in the ProjectX India – 01-10-2024 PDF Edition.
Click here to buy this copy for Rs 469 only or go for an annual subscription.
#New-Projects-In-India-01-10-2024-97
*Image used in this post if any is for illustration only
What are the upcoming Drugs/Pharma projects in India?
Access Drugs/Pharma sector projects in India
Stay ahead in the world of Construction Projects, Industrial Projects, and Infrastructure Projects with ProjectX India’s exclusive fortnightly editions. Your trusted source for the latest consultancy opportunities, we deliver essential updates on upcoming and ongoing projects across sectors, including construction, industrial, steel, ethanol, pharmaceuticals, and chemicals. Gain exclusive access to project trackers, contract awards, and tenders that can drive your business forward. Subscribe today to stay connected with actionable project insights and key contacts, empowering you to succeed in India’s dynamic project landscape.
Click here to download a sample evaluation copy: Explore New Projects, Ongoing Projects, Contract Awards, and Public Procurement Opportunities in India.
For subscriptions or buying this edition, you can Whatsapp us at +91 877 927 9155 or click here.